Employee Highlight: Deepak Singh, Ph.D., Manager, Strategic Planning

Deepak joined Rosetta Biosoftware in 2006. In this interview, he describes strategic planning and how he sees Rosetta Biosoftware empowering customers who use bioinformatics technologies in regulatory settings.

Deepak will be presenting on the Rosetta Syllego system at a breakfast workshop, Tuesday, June 10 at the Beyond Genome conference in San Francisco, CA.

What is your background?

I have my Ph.D. in physical chemistry. My research background is in quantum chemistry and molecular dynamics. I got into bioinformatics when I worked for a start-up in San Diego, developing algorithms. I then moved onto Accelrys, first as product manager for the life science simulation product line and briefly as director of their NanoBiology Initiative. I then became enamored with Seattle and what Rosetta Biosoftware had to offer and relocated here.

What is strategic planning?

In this industry, technology is always evolving and changing. My role is to keep tabs on how technology is evolving, and anticipate the impact of those changes to help guide product development and strategic decisions, such as whom we could partner with.

By taking on this role, I allow product managers to focus on their current products; I also work with product marketing and development to plan where they can go 2-3 years into the future.

Overall, I look for ways Rosetta Biosoftware can evolve to meet our customer's changing needs, and therefore facilitate our customers to be successful.

How do you validate and communicate strategies for Rosetta Biosoftware's technologies?

I am also taking on the role of what might be best described as a "technology evangelist." This role allows me to talk about how Rosetta Biosoftware technology can be used to address various pain points, and listen to feedback about our technologies.

How do you see Rosetta Biosoftware responding to an evolving clinical and preclinical environment?

It's becoming more clear that genetic and genomics technologies are starting to play a bigger role in clinical and preclinical research. For example, the FDA's VXDS (Voluntary Exploratory Data Submissions) program is encouraging companies to think about the kind of genomic data they might want to submit in support of a new or existing drug.

At Rosetta Biosoftware, we are empowering our customers to successfully make these technologies a part of their regulatory submissions by adopting standards and enabling compliance, etc.

What do you like best about your job?

I love doing market research and using a variety of tools to gather information about the industry. While it is a small activity, one of my favorite tasks is to filter information that I find relevant and distribute it to senior and executive staff in the form of an intelligence newsletter. The newsletter often highlights various market dynamics with a potential impact on our business down the road.

What do you like best about Seattle?

It's a great place for techies to live!

User login